Baidu
map

Nat Commun:新的成像技术可在动脉粥样硬化早期做出诊断

2015-07-15 MedSci MedSci原创

新的成像技术可在动脉粥样硬化早期做出诊断动脉粥样硬化是指脂肪沉积堵塞动脉使血流量和氧的供应量减小,可导致心脏疾病和中风。现在,有研究人员称,受益于价格低廉可重新应用的放射性战剂,我们可以通过一种无创成像系统识别动脉粥样硬化的早期阶段。来自自英国剑桥大学和爱丁堡大学的研究人员在Nature Communications上描述了他们是如何使用放射性战剂(20世纪60年代首次提出用以检测骨癌)突出患者动





动脉粥样硬化是指脂肪沉积堵塞动脉使血流量和氧的供应量减小,可导致心脏疾病和中风。现在,有研究人员称,受益于价格低廉可重新应用的放射性战剂,我们可以通过一种无创成像系统识别动脉粥样硬化的早期阶段。


来自自英国剑桥大学和爱丁堡大学的研究人员在Nature Communications上描述了他们是如何使用放射性战剂(20世纪60年代首次提出用以检测骨癌)突出患者动脉内不稳定性的钙沉积。

该研究负责人Dr. Anthony Davenport说道,“新兴技术是无创检测不稳定性斑块早期钙化的唯一成像平台。他以及他的同事希望该技术(使用氟化钠加上少量放射性示踪剂)可有助于动脉粥样硬化的诊断以及新的治疗药物的研发。

动脉粥样硬化存在好几种危险,其中之一便是逐渐积聚的脂肪(斑块)钙化变硬是官腔变得狭窄,最终可影响血液的流动和氧气的供应。另一种是某些情况下,碎片可从斑块中脱落,碎片脱落发生在心脏或大脑区域的动脉,则可引起动脉堵塞,导致中风或心脏疾病发作。

清楚的是,动脉粥样硬化可以导致严重的疾病,但是我们并不清楚哪些人容易形成这种碎片易剥脱的不稳定性斑块,因此越早确定这些易感人群,就会有越好的机会对其进行早期治疗,挽救他们的生命。

该研究中,研究人员向研究对象注入了放射性氟化钠示踪剂(18F-NaF)。由于18F-NaF体内移动的速度很快,故联合使用成像技术(正电子发射断层扫描好额计算机断层扫描,或PET/CT)进行成像。

“氟化钠是牙膏的基本成分,可与牙釉质中的钙化物结合,”Dr. Davenport解释道,“相似的,氟化钠可以结合至动脉不稳定钙化区,所以我们可以通过测量放射性物质的水平观察到哪些部位正发生动脉粥样硬化。”

扫描后,患者进行手术以移除斑块,然后研究人员使用高分辨率的PET/CT扫描仪和电子显微镜对其进行更高精确度的检测。

详细检查的结果证实18F-NaF示踪剂可结合在活跃性,不稳定钙沉积区域,而不是周围组织。
共同第一作者Dr. James Rudd,剑桥大学心脏病专家和研究员,说道,18F-NaF是种简单且廉价的示踪剂,应彻底变革医生检测心脏和大脑区域动脉中钙沉积的能力。

他总结道:

“通过给高危人群注射这种示踪剂,使得我们能更有效地利用现有的治疗方法。此外,经进一步的研究,使用这种技术测试新药预防动脉粥样硬化的效果成为可能。”

原始出处:

Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, Joshi FR, Gallagher FA, Warburton EA, Bennett MR, Brindle KM, Newby DE, Rudd JH, Davenport AP.Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun. 2015 Jul 7;6:7495. doi: 10.1038/ncomms8495.



版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1880727, encodeId=6b3f1880e2745, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 00:15:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944385, encodeId=0641194438539, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Aug 22 04:15:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086806, encodeId=f2e120868068c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Apr 15 03:15:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763638, encodeId=3faf1e6363881, content=<a href='/topic/show?id=38ef31483b3' target=_blank style='color:#2F92EE;'>#出诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31483, encryptionId=38ef31483b3, topicName=出诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ab37545452, createdName=thinkibmz_44722606, createdTime=Thu Feb 18 12:15:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33181, encodeId=c22333181e2, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Jul 21 00:20:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32924, encodeId=717132924f7, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Thu Jul 16 18:33:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32893, encodeId=b5a4328934f, content=不久的将来,会不会真的有长生不老药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB1WyQmmv2iazjCicO1CnvpCXOlCjJ1xJjmOQowmd5bSxCtVMicaZs7icQkxicMQCzTXgk8GEBKxnYuCxw/0, createdBy=ecf81608992, createdName=wxsessiond1c0d06a, createdTime=Thu Jul 16 16:37:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570731, encodeId=e15415e0731bb, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Jul 16 15:15:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32862, encodeId=3b8b32862ee, content=希望, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Thu Jul 16 10:04:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
    2015-10-07 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1880727, encodeId=6b3f1880e2745, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 00:15:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944385, encodeId=0641194438539, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Aug 22 04:15:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086806, encodeId=f2e120868068c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Apr 15 03:15:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763638, encodeId=3faf1e6363881, content=<a href='/topic/show?id=38ef31483b3' target=_blank style='color:#2F92EE;'>#出诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31483, encryptionId=38ef31483b3, topicName=出诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ab37545452, createdName=thinkibmz_44722606, createdTime=Thu Feb 18 12:15:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33181, encodeId=c22333181e2, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Jul 21 00:20:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32924, encodeId=717132924f7, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Thu Jul 16 18:33:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32893, encodeId=b5a4328934f, content=不久的将来,会不会真的有长生不老药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB1WyQmmv2iazjCicO1CnvpCXOlCjJ1xJjmOQowmd5bSxCtVMicaZs7icQkxicMQCzTXgk8GEBKxnYuCxw/0, createdBy=ecf81608992, createdName=wxsessiond1c0d06a, createdTime=Thu Jul 16 16:37:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570731, encodeId=e15415e0731bb, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Jul 16 15:15:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32862, encodeId=3b8b32862ee, content=希望, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Thu Jul 16 10:04:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1880727, encodeId=6b3f1880e2745, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 00:15:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944385, encodeId=0641194438539, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Aug 22 04:15:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086806, encodeId=f2e120868068c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Apr 15 03:15:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763638, encodeId=3faf1e6363881, content=<a href='/topic/show?id=38ef31483b3' target=_blank style='color:#2F92EE;'>#出诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31483, encryptionId=38ef31483b3, topicName=出诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ab37545452, createdName=thinkibmz_44722606, createdTime=Thu Feb 18 12:15:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33181, encodeId=c22333181e2, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Jul 21 00:20:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32924, encodeId=717132924f7, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Thu Jul 16 18:33:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32893, encodeId=b5a4328934f, content=不久的将来,会不会真的有长生不老药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB1WyQmmv2iazjCicO1CnvpCXOlCjJ1xJjmOQowmd5bSxCtVMicaZs7icQkxicMQCzTXgk8GEBKxnYuCxw/0, createdBy=ecf81608992, createdName=wxsessiond1c0d06a, createdTime=Thu Jul 16 16:37:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570731, encodeId=e15415e0731bb, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Jul 16 15:15:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32862, encodeId=3b8b32862ee, content=希望, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Thu Jul 16 10:04:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
    2016-04-15 liuli5079
  4. [GetPortalCommentsPageByObjectIdResponse(id=1880727, encodeId=6b3f1880e2745, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 00:15:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944385, encodeId=0641194438539, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Aug 22 04:15:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086806, encodeId=f2e120868068c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Apr 15 03:15:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763638, encodeId=3faf1e6363881, content=<a href='/topic/show?id=38ef31483b3' target=_blank style='color:#2F92EE;'>#出诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31483, encryptionId=38ef31483b3, topicName=出诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ab37545452, createdName=thinkibmz_44722606, createdTime=Thu Feb 18 12:15:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33181, encodeId=c22333181e2, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Jul 21 00:20:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32924, encodeId=717132924f7, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Thu Jul 16 18:33:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32893, encodeId=b5a4328934f, content=不久的将来,会不会真的有长生不老药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB1WyQmmv2iazjCicO1CnvpCXOlCjJ1xJjmOQowmd5bSxCtVMicaZs7icQkxicMQCzTXgk8GEBKxnYuCxw/0, createdBy=ecf81608992, createdName=wxsessiond1c0d06a, createdTime=Thu Jul 16 16:37:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570731, encodeId=e15415e0731bb, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Jul 16 15:15:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32862, encodeId=3b8b32862ee, content=希望, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Thu Jul 16 10:04:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1880727, encodeId=6b3f1880e2745, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 00:15:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944385, encodeId=0641194438539, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Aug 22 04:15:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086806, encodeId=f2e120868068c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Apr 15 03:15:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763638, encodeId=3faf1e6363881, content=<a href='/topic/show?id=38ef31483b3' target=_blank style='color:#2F92EE;'>#出诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31483, encryptionId=38ef31483b3, topicName=出诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ab37545452, createdName=thinkibmz_44722606, createdTime=Thu Feb 18 12:15:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33181, encodeId=c22333181e2, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Jul 21 00:20:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32924, encodeId=717132924f7, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Thu Jul 16 18:33:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32893, encodeId=b5a4328934f, content=不久的将来,会不会真的有长生不老药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB1WyQmmv2iazjCicO1CnvpCXOlCjJ1xJjmOQowmd5bSxCtVMicaZs7icQkxicMQCzTXgk8GEBKxnYuCxw/0, createdBy=ecf81608992, createdName=wxsessiond1c0d06a, createdTime=Thu Jul 16 16:37:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570731, encodeId=e15415e0731bb, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Jul 16 15:15:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32862, encodeId=3b8b32862ee, content=希望, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Thu Jul 16 10:04:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
    2015-07-21 qingfengqishi5

    收藏了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1880727, encodeId=6b3f1880e2745, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 00:15:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944385, encodeId=0641194438539, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Aug 22 04:15:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086806, encodeId=f2e120868068c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Apr 15 03:15:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763638, encodeId=3faf1e6363881, content=<a href='/topic/show?id=38ef31483b3' target=_blank style='color:#2F92EE;'>#出诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31483, encryptionId=38ef31483b3, topicName=出诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ab37545452, createdName=thinkibmz_44722606, createdTime=Thu Feb 18 12:15:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33181, encodeId=c22333181e2, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Jul 21 00:20:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32924, encodeId=717132924f7, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Thu Jul 16 18:33:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32893, encodeId=b5a4328934f, content=不久的将来,会不会真的有长生不老药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB1WyQmmv2iazjCicO1CnvpCXOlCjJ1xJjmOQowmd5bSxCtVMicaZs7icQkxicMQCzTXgk8GEBKxnYuCxw/0, createdBy=ecf81608992, createdName=wxsessiond1c0d06a, createdTime=Thu Jul 16 16:37:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570731, encodeId=e15415e0731bb, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Jul 16 15:15:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32862, encodeId=3b8b32862ee, content=希望, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Thu Jul 16 10:04:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
    2015-07-16 1dd8ea20m15(暂无匿称)

    了解了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1880727, encodeId=6b3f1880e2745, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 00:15:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944385, encodeId=0641194438539, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Aug 22 04:15:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086806, encodeId=f2e120868068c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Apr 15 03:15:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763638, encodeId=3faf1e6363881, content=<a href='/topic/show?id=38ef31483b3' target=_blank style='color:#2F92EE;'>#出诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31483, encryptionId=38ef31483b3, topicName=出诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ab37545452, createdName=thinkibmz_44722606, createdTime=Thu Feb 18 12:15:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33181, encodeId=c22333181e2, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Jul 21 00:20:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32924, encodeId=717132924f7, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Thu Jul 16 18:33:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32893, encodeId=b5a4328934f, content=不久的将来,会不会真的有长生不老药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB1WyQmmv2iazjCicO1CnvpCXOlCjJ1xJjmOQowmd5bSxCtVMicaZs7icQkxicMQCzTXgk8GEBKxnYuCxw/0, createdBy=ecf81608992, createdName=wxsessiond1c0d06a, createdTime=Thu Jul 16 16:37:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570731, encodeId=e15415e0731bb, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Jul 16 15:15:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32862, encodeId=3b8b32862ee, content=希望, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Thu Jul 16 10:04:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
    2015-07-16 wxsessiond1c0d06a

    不久的将来,会不会真的有长生不老药?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1880727, encodeId=6b3f1880e2745, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 00:15:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944385, encodeId=0641194438539, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Aug 22 04:15:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086806, encodeId=f2e120868068c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Apr 15 03:15:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763638, encodeId=3faf1e6363881, content=<a href='/topic/show?id=38ef31483b3' target=_blank style='color:#2F92EE;'>#出诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31483, encryptionId=38ef31483b3, topicName=出诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ab37545452, createdName=thinkibmz_44722606, createdTime=Thu Feb 18 12:15:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33181, encodeId=c22333181e2, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Jul 21 00:20:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32924, encodeId=717132924f7, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Thu Jul 16 18:33:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32893, encodeId=b5a4328934f, content=不久的将来,会不会真的有长生不老药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB1WyQmmv2iazjCicO1CnvpCXOlCjJ1xJjmOQowmd5bSxCtVMicaZs7icQkxicMQCzTXgk8GEBKxnYuCxw/0, createdBy=ecf81608992, createdName=wxsessiond1c0d06a, createdTime=Thu Jul 16 16:37:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570731, encodeId=e15415e0731bb, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Jul 16 15:15:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32862, encodeId=3b8b32862ee, content=希望, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Thu Jul 16 10:04:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1880727, encodeId=6b3f1880e2745, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Oct 07 00:15:00 CST 2015, time=2015-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1944385, encodeId=0641194438539, content=<a href='/topic/show?id=411de6300ad' target=_blank style='color:#2F92EE;'>#粥样硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76300, encryptionId=411de6300ad, topicName=粥样硬化)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sat Aug 22 04:15:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2086806, encodeId=f2e120868068c, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Fri Apr 15 03:15:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1763638, encodeId=3faf1e6363881, content=<a href='/topic/show?id=38ef31483b3' target=_blank style='color:#2F92EE;'>#出诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31483, encryptionId=38ef31483b3, topicName=出诊)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14ab37545452, createdName=thinkibmz_44722606, createdTime=Thu Feb 18 12:15:00 CST 2016, time=2016-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=33181, encodeId=c22333181e2, content=收藏了, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Tue Jul 21 00:20:00 CST 2015, time=2015-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32924, encodeId=717132924f7, content=了解了, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9c501632215, createdName=1dd8ea20m15(暂无匿称), createdTime=Thu Jul 16 18:33:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32893, encodeId=b5a4328934f, content=不久的将来,会不会真的有长生不老药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB1WyQmmv2iazjCicO1CnvpCXOlCjJ1xJjmOQowmd5bSxCtVMicaZs7icQkxicMQCzTXgk8GEBKxnYuCxw/0, createdBy=ecf81608992, createdName=wxsessiond1c0d06a, createdTime=Thu Jul 16 16:37:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1570731, encodeId=e15415e0731bb, content=<a href='/topic/show?id=03d55395183' target=_blank style='color:#2F92EE;'>#成像技术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53951, encryptionId=03d55395183, topicName=成像技术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6b515702368, createdName=photoman, createdTime=Thu Jul 16 15:15:00 CST 2015, time=2015-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=32862, encodeId=3b8b32862ee, content=希望, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=acd01628312, createdName=1dd82894m82(暂无匿称), createdTime=Thu Jul 16 10:04:00 CST 2015, time=2015-07-16, status=1, ipAttribution=)]
    2015-07-16 1dd82894m82(暂无匿称)

    希望

    0

相关资讯

Radiology:断层融合技术可提高乳房X光成像**度

  一项发表在《放射学》杂志1月刊上的研究显示,将断层融合技术(对乳房进行三围成像)与数字乳房X线摄影结合起来可提高放射肿瘤诊断精确度,同时还能大大降低非癌症病例的回诊次数。   来自美国麻省总医院的Elizabeth A. Rafferty博士和同事们进行了一项多中心试验,共涉及1192名女性,这些女性均接受了双乳房内外斜位和头尾位的数字X光成像和断层融合成像。放射肿瘤学家然后对同时接受这两种

科学家绘制大脑结构图

  据英国每日邮报报道,科学家最新绘制出大脑如何处理每天观看数千幅图像的结构分布图,美国加州伯克利分校研究小组发现大脑所关联的日常生活看到的所有物体分类。   为了图解说明这项研究发现,他们建造了第一张分布在大脑皮层的物质分类结构图。当测试者观看视频剪辑数个小时,计算机模型获得了大脑成像数据。   加州伯克利分校研究小组在大脑皮层绘制这一数据结构,从而显示日常生活中人们所接触周围物

新成像软件发现癌症,取代病理学家

 MedSci评论:  这是首例用计算机智能成像和分析技术, 用于乳腺癌的诊断, 用于取代病理医生. 这是重要的趋势,通过计算机大规模计算技术,为临床诊断和治疗提供有价值的线索.不仅在肿瘤,甚至其它疾病,也能提供高可靠性的诊断. 同样,我国的科研工作者应该密切注意这方面的动态, 提升临床研究的价值. 新的成像软件可能与病理学家的眼睛相媲美。 研究人员创建了一种叫做

癌症成像学研究(斯坦福大学公开课)

癌症成像学研究(斯坦福大学公开课)

Baidu
map
Baidu
map
Baidu
map